S
Sunzen Biotech Bhd
KLSE:SUNZEN
Sunzen Biotech Bhd
KLSE:SUNZEN
Price:
0.25
MYR
Market Cap:
203.9m
MYR
Balance Sheet
Balance Sheet Decomposition
Sunzen Biotech Bhd
Sunzen Biotech Bhd
Balance Sheet Decomposition is not available for
Sunzen Biotech Bhd
Sunzen Biotech Bhd
Balance Sheet
Sunzen Biotech Bhd
Sunzen Biotech Bhd
Currency: MYR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
9
|
7
|
51
|
47
|
42
|
33
|
39
|
47
|
12
|
28
|
11
|
|
| Cash |
9
|
7
|
0
|
0
|
42
|
33
|
39
|
47
|
12
|
28
|
11
|
|
| Cash Equivalents |
0
|
0
|
51
|
47
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
6
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Total Receivables |
0
|
0
|
9
|
28
|
27
|
19
|
11
|
15
|
22
|
20
|
37
|
|
| Accounts Receivables |
0
|
0
|
6
|
23
|
21
|
14
|
8
|
13
|
20
|
15
|
17
|
|
| Other Receivables |
0
|
0
|
3
|
5
|
6
|
5
|
4
|
2
|
1
|
5
|
19
|
|
| Inventory |
0
|
0
|
11
|
6
|
14
|
12
|
12
|
14
|
11
|
9
|
10
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
13
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
71
|
81
|
83
|
66
|
76
|
76
|
45
|
57
|
65
|
|
| PP&E Net |
0
|
0
|
35
|
38
|
62
|
62
|
47
|
48
|
47
|
55
|
40
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
55
|
54
|
71
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
106
N/A
|
119
+12%
|
148
+24%
|
128
-13%
|
123
-4%
|
149
+21%
|
151
+2%
|
170
+13%
|
182
+7%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
2
|
15
|
13
|
6
|
6
|
10
|
9
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
3
|
0
|
1
|
1
|
10
|
1
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
1
|
2
|
10
|
5
|
5
|
5
|
3
|
3
|
4
|
|
| Total Current Liabilities |
0
|
0
|
6
|
17
|
25
|
12
|
21
|
15
|
13
|
8
|
10
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
4
|
16
|
5
|
5
|
5
|
7
|
19
|
|
| Deferred Income Tax |
0
|
0
|
1
|
1
|
3
|
3
|
3
|
4
|
4
|
5
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
8
|
6
|
6
|
7
|
8
|
10
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
9
N/A
|
20
+119%
|
41
+106%
|
37
-9%
|
36
-3%
|
31
-14%
|
29
-5%
|
31
+6%
|
33
+8%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
48
|
63
|
76
|
77
|
77
|
108
|
110
|
112
|
135
|
|
| Retained Earnings |
0
|
0
|
24
|
36
|
32
|
16
|
12
|
11
|
15
|
8
|
11
|
|
| Additional Paid In Capital |
7
|
0
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
13
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
10
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
97
N/A
|
99
+2%
|
107
+8%
|
91
-15%
|
87
-4%
|
118
+35%
|
122
+3%
|
139
+14%
|
149
+7%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
106
N/A
|
119
+12%
|
148
+24%
|
128
-13%
|
123
-4%
|
149
+21%
|
151
+2%
|
170
+13%
|
182
+7%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
478
|
482
|
524
|
529
|
529
|
706
|
705
|
713
|
772
|
|
Switch to:
Switch to:
See Also
Discover More
